Upexi, Inc. (NASDAQ:UPXI – Get Free Report) was the recipient of a significant increase in short interest during the month of January. As of January 31st, there was short interest totalling 36,800 shares, an increase of 323.0% from the January 15th total of 8,700 shares. Based on an average daily volume of 157,000 shares, the short-interest ratio is presently 0.2 days. Approximately 4.9% of the shares of the stock are short sold.
Hedge Funds Weigh In On Upexi
An institutional investor recently bought a new position in Upexi stock. Bank of Montreal Can acquired a new stake in shares of Upexi, Inc. (NASDAQ:UPXI – Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 10,008 shares of the company’s stock, valued at approximately $36,000. Bank of Montreal Can owned about 0.81% of Upexi at the end of the most recent quarter. Institutional investors and hedge funds own 5.68% of the company’s stock.
Upexi Price Performance
Shares of Upexi stock opened at $4.00 on Friday. The company has a current ratio of 0.69, a quick ratio of 0.53 and a debt-to-equity ratio of 0.39. Upexi has a 12 month low of $2.17 and a 12 month high of $28.00. The business’s 50-day moving average price is $4.06 and its 200-day moving average price is $4.37.
About Upexi
Upexi, Inc manufactures and sells various branded products in the health, wellness, pet, beauty, and other markets. The company was formerly known as Grove, Inc and changed its name to Upexi, Inc in August 2022. The company was incorporated in 2018 and is headquartered in Clearwater, Florida.
Read More
- Five stocks we like better than Upexi
- What Are Dividend Contenders? Investing in Dividend Contenders
- Upstart’s Uptrend Is Just Getting Started: Its Time to Load Up
- How to Evaluate a Stock Before Buying
- Archer Aviation Lands BlackRock Investment—What’s Next for ACHR?
- Growth Investing: Should You Adopt This Investing Strategy in 2022?
- Buffett Buys More Occidental Petroleum—Sticking to His Playbook
Receive News & Ratings for Upexi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Upexi and related companies with MarketBeat.com's FREE daily email newsletter.